Efficacy of the iron‐chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta‐analysis

Documenti analoghi

• Determining the role of statins in Parkinson's disease risk reduction and disease modification: A comprehensive meta‐analysis of 4 million participants' data
  di: Abdelrahman Mady, et al.
  Pubblicazione: (2024)
• Levodopa and Plant‐Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives
  di: Emre Aktaş, et al.
  Pubblicazione: (2025)
• The relationship between physical function and psychological symptoms in Parkinson's disease: A systematic review and meta‐regression analysis
  di: Philip Hodgson, et al.
  Pubblicazione: (2024)
• Neuroprotective effects of punicalagin and/or micronized zeolite clinoptilolite on manganese‐induced Parkinson's disease in a rat model: Involvement of multiple pathways
  di: Karema Abu‐Elfotuh, et al.
  Pubblicazione: (2024)
• Myelin endocytosis by brain endothelial cells causes endothelial iron overload and oligodendroglial iron hunger in hypoperfusion‐induced white matter injury
  di: Yuxin Liu, et al.
  Pubblicazione: (2024)